January 19, 2021
1 min read

Pak Approves Emergency Use Of Sinopharm Vaccine

The Drug Regulatory Authority of Pakistan (DRAP) has approved a Covid-19 vaccine by China’s Sinopharm for emergency use amid an unabated resurgence in the country.

A handout by DRAP on its official website late Monday said that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality, Xinhua news agency reported.

The handout added that the authorization will be reviewed every quarter keeping in view further data regarding safety, efficacy and quality.

Meanwhile, another vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca was been given the authorization earlier, the handout said.

Chaudhry Fawad Hussain, the country’s Minister for Science and Technology, told Xinhua earlier that the Sinopharm vaccine has been approved for procurement by a cabinet committee for its safety and affordability.

Imran Khan

Pakistan reported 1,920 new coronavirus infections and 46 deaths in the last 24 hours, bringing the total number of cases to 521,211 with 10,997 fatalities.

Also Read-Mass Covid vaccine campaign begins in Brazil

Read More-Melania gives farewell address to American people

Previous Story

UN voices concern over US’ Houthi designation

Next Story

Biden denies Trump plan to lift travel ban

Latest from -Top News

EU leaders to be chief guests at R-Day

Move will be a historic first for India marking deepening ties amid global geopolitical shifts In a first for Indian diplomacy, New Delhi is set to invite the leadership of the European

India, Russia vow deeper defence ties

The fifth meeting of the Working Group reviewed current defence cooperation plans and explored new avenues for collaboration and knowledge-sharing….reports Asian Lite News India and Russia held their fifth Meeting of the
Go toTop